{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:23:08Z","timestamp":1790666588086,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bpobgyn.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T05:46:24Z","timestamp":1408772784000},"page":"1251-1265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Epidemiology of de novo malignancies after solid-organ transplantation: Immunosuppression, infection and other risk factors"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7342-0263","authenticated-orcid":false,"given":"Pierluca","family":"Piselli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Verdirosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cimaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghil","family":"Busnach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fratino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Maria","family":"Ettorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"De Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Serraino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.08.007_bib1","unstructured":"Global Transplant data: Graphics and tables. Organ Donation and Transplantation Activities. Available at: http:\/\/www.transplant-observatory.org [accessed 01.07.14]."},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.trre.2012.07.001","article-title":"New concepts and best practices for management of pre- and post-transplantation cancer","volume":"26","author":"Campistol","year":"2012","journal-title":"Transplant Rev"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.24439","article-title":"Cancer incidence and risk factors after solid organ transplantation","volume":"125","author":"Vajdic","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib5","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ijc.24741","article-title":"Cancer and viral infections in immunocompromised individuals","volume":"125","author":"Schulz","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trre.2008.05.001","article-title":"Pregnancy after transplantation","volume":"22","author":"Armenti","year":"2008","journal-title":"Transplantation Review"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumour escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib8","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/01.TP.0000120181.89206.54","article-title":"Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation","volume":"77","author":"Guba","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib9","doi-asserted-by":"crossref","first-page":"c570","DOI":"10.1136\/bmj.c570","article-title":"Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study","volume":"340","author":"van Leeuwen","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOT.0000000000000069","article-title":"Liver transplantation: immunosuppression and oncology","volume":"19","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.TP.0000081399.75231.3B","article-title":"Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumour progression","volume":"76","author":"Maluccio","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1523-1755.2003.00757.x","article-title":"Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity","volume":"63","author":"Shihab","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib14","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood.V84.11.3956.bloodjournal84113956","article-title":"Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease","volume":"84","author":"Tanner","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.273.5278.1109","article-title":"Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine","volume":"273","author":"Swann","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.leukres.2006.12.019","article-title":"Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas","volume":"31","author":"V\u00e9gso","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007890-199901150-00030","article-title":"Five cases of Kaposi's sarcoma in kidney graft recipients: possible influence of the immunosuppressive therapy","volume":"67","author":"Eberhard","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ndt\/15.7.1103","article-title":"Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead","volume":"15","author":"Hussein","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/TP.0b013e318193886e","article-title":"The role of mTOR inhibitors in the management of post-transplant malignancy","volume":"87","author":"Monaco","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib21","first-page":"4472","article-title":"Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas","volume":"63","author":"Nepomuceno","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumour growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib23","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft- protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib24","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JVI.75.6.2929-2937.2001","article-title":"Linkage between STAT regulation and Epstein-Barr virus gene expression in tumours","volume":"75","author":"Chen","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Gobal burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"De Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib26","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib27","first-page":"224","article-title":"Viral infections and cancer: epidemiological aspects","volume":"15","author":"Serraino","year":"2001","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/15665240113139990041","article-title":"De novo malignancies after organ transplantation: focus on viral infections","volume":"13","author":"Piselli","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A\u00a0review of human carcinogens. part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib31","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib32","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4725.2012.02558.x","article-title":"Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?","volume":"39","author":"Aldabagh","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2014.01.857","article-title":"Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis","volume":"70","author":"Wang","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/OAS.S14720","article-title":"Organ transplantation from deceased donors with cancer: is it safe?","volume":"4","author":"Nalesnik","year":"2011","journal-title":"Open Access Surgery"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib37","first-page":"39","article-title":"European best practice guidelines for renal transplantation (part 1). Section II. Evaluation and selection of donors","volume":"15","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.6002\/ect.25Liver.L49","article-title":"Donor-transmitted, donor-derived, and de novo cancer after liver transplant","volume":"S1","author":"Chapman","year":"2014","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.TP.0000146258.79425.04","article-title":"Age and immune response in organ transplantation","volume":"79","author":"Martins","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib40","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(00)02298-4","article-title":"Cancer risk in patients on dialysis and after renal transplantation","volume":"355","author":"Birkeland","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib41","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/00007890-199912270-00008","article-title":"Risk factors for cancer in renal transplant recipients","volume":"68","author":"Danpanich","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/jlts.2002.32977","article-title":"Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation","volume":"8","author":"Saigal","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1600-6143.2004.00380.x","article-title":"De novo internal neoplasms after liver transplantation: increased risk and aggressive behaviour in recent years?","volume":"4","author":"Benlloch","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib44","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/S0041-1345(03)00641-9","article-title":"Upper aerodigestive tract and lung tumours after liver transplantation","volume":"35","author":"Jim\u00e9nez","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nm0496-457","article-title":"Acute alcohol intoxication suppresses natural killer cell activity and promotes tumour metastasis","volume":"2","author":"Ben-Eliyahu","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib46","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sj.bjc.6602306","article-title":"Second primary cancers in patients with squamous cell carcinoma of the skin","volume":"92","author":"Maitra","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib47","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1111\/j.1432-2277.2000.tb02068.x","article-title":"Cancer incidence in a kidney-transplanted population","volume":"13","author":"Kyllonen","year":"2000","journal-title":"Tranpl Int"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib48","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2013a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/ajkd.2000.8290","article-title":"Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients","volume":"36","author":"Ramsay","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0041-1345(96)00152-2","article-title":"Skin tumours posttransplantation: a retrospective analysis of 28 years\u2019 experience at a single centre","volume":"29","author":"Webb","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.139.3.301","article-title":"Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study","volume":"139","author":"Martinez","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib52","first-page":"532","article-title":"Cutaneous neoplasms in renal transplant recipients","volume":"12","author":"Rubel","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib53","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.mot.0000146559.20280.29","article-title":"The relation between immunosuppressive agents and malignancy","volume":"9","author":"Geisller","year":"2004","journal-title":"Curr Opin Org Transp"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-08-0919","article-title":"Immunosuppression and other risk factors for lip cancer after kidney transplantation","volume":"18","author":"van Leeuwen","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib56","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/cancers6031328","article-title":"Merkel cell carcinoma in immunosuppressed patients","volume":"6","author":"Ma","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","article-title":"Immunodeficiency-associated lymphomas","volume":"22","author":"Tran","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib59","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00007890-199904150-00010","article-title":"Lymphoproliferative disorders after organ transplantation in children","volume":"67","author":"Dror","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib60","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.mehy.2003.11.001","article-title":"EBV-associated neoplasms: alternative pathogenetic pathways","volume":"62","author":"Niller","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1053-2498(02)01229-9","article-title":"Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University","volume":"22","author":"Gao","year":"2003","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1600-6135.2003.00274.x","article-title":"Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients","volume":"4","author":"Bustami","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Alberu J at al. Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib65","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.TP.0000100826.58738.2B","article-title":"Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation","volume":"76","author":"Cherikh","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib66","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib67","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib68","first-page":"S3945","article-title":"A\u00a0pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation","volume":"9","author":"Orjuela","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-199501000-00016","article-title":"Central nervous system lymphomas in organ allograft recipients","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib70","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00277-007-0298-2","article-title":"Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution","volume":"86","author":"Choquet","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib71","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ndt\/gfm088","article-title":"Post-transplant lymphoproliferative disorder\u2013the potential of proliferation signal inhibitors","volume":"22","author":"Pascual","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trre.2008.05.004","article-title":"Kaposi sarcoma in transplantation","volume":"22","author":"Lebb\u00e9","year":"2008","journal-title":"Transplant Rev"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib73","first-page":"616","article-title":"Skin cancers following paediatric organ transplantation","volume":"30","author":"Euvrard","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib74","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","article-title":"Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009","volume":"49","author":"Piselli","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1525-1594.2004.00019.x","article-title":"Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients","volume":"28","author":"Zavos","year":"2004","journal-title":"Artif Organs"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trim.2006.09.008","article-title":"Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain","volume":"17","author":"Garc\u00eda-Astudillo","year":"2006","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib77","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11255-008-9483-z","article-title":"Kaposi's sarcoma following living donor kidney transplantation: review of 7,939 recipients","volume":"41","author":"Einollahi","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib78","first-page":"1402","article-title":"Kaposi\u2019s sarcoma in renal transplant recipients: a report on 26 cases from a single institution","volume":"25","author":"Qunibi","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib79","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.transproceed.2004.12.034","article-title":"Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis","volume":"37","author":"Berber","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib80","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1046\/j.1600-6135.2003.00276.x","article-title":"Clinical features and course of Kaposi's sarcoma in Egyptian kidney transplant recipients","volume":"3","author":"El-Agroudy","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib81","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/00002030-200308150-00001","article-title":"Human herpesvirus 8 epidemiology: what we do and do not know","volume":"17","author":"Dukers","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib82","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/j.1600-6143.2009.02816.x","article-title":"Skin and Organ Transplantation Group of the French Society of Dermatology. The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival","volume":"9","author":"Franc\u00e8s","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib83","first-page":"195","article-title":"Prevalence, incidence and correlates of HHV8\/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients","volume":"3","author":"Andreoni","year":"2001","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib84","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/01.tp.0000187864.65522.10","article-title":"Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France","volume":"80","author":"Serraino","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib85","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1086\/377173","article-title":"Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor","volume":"37","author":"Luppi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib86","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.1997.15.6.2371","article-title":"Treatment of Kaposi's sarcoma after solid organ transplantation","volume":"15","author":"Shepherd","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib87","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi's sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ndt\/gfm652","article-title":"Sirolimus in renal transplantation","volume":"22","author":"Morath","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib89","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.trre.2005.01.001","article-title":"Rapamycin and tumour growth: mechanisms behind its anticancer activity","volume":"19","author":"Koehl","year":"2005","journal-title":"Transplant Rev"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib90","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4161\/cc.6.4.3843","article-title":"Akt\/TSC\/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma","volume":"6","author":"Montaner","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2004.11.010","article-title":"Cancer incidence after immunosuppressive treatment following kidney transplantation","volume":"56","author":"Andr\u00e9s","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib92","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1634\/theoncologist.2007-0251","article-title":"Malignancy after solid organ transplantation: an overview","volume":"13","author":"Zafar","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib93","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2215\/CJN.03661106","article-title":"Renal cell carcinoma in transplant recipients with acquired cystic kidney disease","volume":"2","author":"Schwarz","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib94","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2215\/CJN.02000507","article-title":"Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening?","volume":"2","author":"Scandling","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib95","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199559040-00006","article-title":"Primary kidney tumours before and after renal transplantation","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib96","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s10350-004-0674-0","article-title":"Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer","volume":"47","author":"Papaconstantinou","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib97","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.07021.x","article-title":"A\u00a0population-based study of skin cancer incidence and prevalence in renal transplant recipients","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib98","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1067\/mtc.2002.124885","article-title":"Primary lung carcinoma after heart or lung transplantation: management and outcome","volume":"124","author":"Anyanwu","year":"2002","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.critrevonc.2005.03.013","article-title":"Incidence of cancer after immunosuppressive treatment for heart transplantation","volume":"56","author":"Ippoliti","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-6143.2012.04302.x","article-title":"Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients","volume":"13","author":"Na","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.08.007_bib101","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1600-6143.2011.03681.x","article-title":"Treatment of kidney transplant recipients with ACEi\/ARB and risk of respiratory tract cancer: a collaborative transplant study report","volume":"11","author":"Opelz","year":"2011","journal-title":"Am J Transplant"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341400176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341400176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T16:49:25Z","timestamp":1598201365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169341400176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S152169341400176X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.08.007","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of de novo malignancies after solid-organ transplantation: Immunosuppression, infection and other risk factors","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}